Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.800
+0.010 (0.56%)
Nov 21, 2024, 11:34 AM EST - Market open
Akebia Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$5.75
Upside
+219.44%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +316.67% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +316.67% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +316.67% | Oct 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +316.67% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $7.5 | Strong Buy | Maintains | $6 → $7.5 | +316.67% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +233.33% | Mar 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +177.78% | Mar 15, 2024 |
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +122.22% | Nov 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.75 → $5 | Strong Buy | Maintains | $3.75 → $5 | +177.78% | Nov 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3.75 | Strong Buy | Reiterates | $3.75 | +108.33% | Sep 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $2 → $3.75 | Hold → Strong Buy | Upgrades | $2 → $3.75 | +108.33% | Aug 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +11.11% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +11.11% | Jun 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +11.11% | Jun 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +11.11% | Jun 2, 2023 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $2 → $4 | Hold → Buy | Upgrades | $2 → $4 | +122.22% | May 31, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.